Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huadong Medicine has brought multiple products to market, including biosimilar liraglutide for diabetes and obesity, several GLP-1 therapeutics (including Phase 2 small molecule oral agents), and its pipeline includes advanced ADCs, bispecific antibodies, and other biologics in oncology, immunology, and metabolism, with ongoing clinical trials in China, UK, and abroad[4][9][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huadong Biological Technology.